Brooks Laboratories Limited

BLL has nearly two decades of industry presence, leading to established relationships with customers and suppliers. The company is engaged in manufacturing pharmaceutical formulations and supplies to reputed players. Experienced management BLL is presently overseen by the collective efforts of its promoters and directors. Promoters , Atul Ranchal and Rajesh Mahajan , each bring nearly two decades of industry experience, complemented by directors , Jitendra Pratap Singh, Dr. Durga Shankar

BLL is presently overseen by the collective efforts of its promoters and directors. Promoters , Atul Ranchal and Rajesh Mahajan , each bring nearly two decades of industry experience, complemented by directors , Jitendra Pratap Singh, Dr. Durga Shankar Maity, and Bhushan Singh Rana, who also possess over 20 years of expertise. Directors are supported by a team of well-versed professionals having rich experience in their respective fields.

Liquidity profile of the company remains stretched, as reflected by high utilisation of working capital limits of ~80% in the last 12 months ending September 2025, and a low free cash and bank balance of ₹0.06 crore as on March 31, 2025. While the company currently does not have term liabilities, the associate company BSL has guaranteed debt of ₹68.62 crore. However, the company is not planning major capex in near -to-medium term, except a regular maintenance/ upgradation capex of ~₹1.0 crore in

Not applicable Environment, social, and governance (ESG) risks Not applicable Applicable criteria Definition of Default Liquidity Analysis of Non-financial sector entities Rating Outlook and Rating Watch

Total operating income 80.29 83.04 25.51 PBILDT 3.90 5.01 3.13 PAT 1.53 3.05 2.65 Overall gearing (times) 0.08 0.07 NA Interest coverage (times) 4.62 4.87 10.43 A: Audited UA: Unaudited NA: Not available; Note: these are latest available financial results Status of non-cooperation with previous CRA: Not applicable

PBILDT 3.90 5.01 3.13 PAT 1.53 3.05 2.65 Overall gearing (times) 0.08 0.07 NA Interest coverage (times) 4.62 4.87 10.43 A: Audited UA: Unaudited NA: Not available; Note: these are latest available financial results Status of non-cooperation with previous CRA: Not applicable Any other information: Not applicable

The company’s scale of operations continues to remain small, with a TOI of ₹83.04 crore in FY25 (April 1, 2024 to March 31, 2025), due to its presence in highly competitive nature of industry . Despite this, the company has some reported improvement in profitability margins as marked by PBILDT and profit after tax (PAT) margins of 6.03% and 3.68%, respectively, in FY25 aga inst 4.86% and 1.90%, respectively, in FY24.

BLL’s overall gearing remains comfortable at 0.07x as on March 31, 2025 , compared to 0.08x as on March 31, 2024. However, owing to guaranteed bank debt of ₹68.62 crore availed by the associate entity, BSL, the company’s financial risk profile remains moderate as marked by an adjusted overall gearing [including corporate guarantee provided to BSL of ₹68.62 crore in FY25 (PY: 65.00 crore) in debt and excluding investment in associate of ₹90.44 crore in FY25 (PY: ₹46.79 crore) from tangible net wo

The pharmaceutical industry is a closely monitored and regulated industry, with inherent risks and liabilities associated with products and manufacturing. Regular compliance with product and manufacturing quality standards prescribed by regulatory authorities is critical for selling products across geographies. BLL is engaged in manufacturing pharmaceutical formulations. The industry is characterised by intense competition due to the presence of numerous small and large players.

Established track record of operations and reputed clientele BLL has nearly two decades of industry presence, leading to established relationships with customers and suppliers. The company is engaged in manufacturing pharmaceutical formulations and supplies to reputed players. Experienced management BLL is presently overseen by the collective efforts of its promoters and directors. Promoters , Atul Ranchal and Rajesh Mahajan ,

BLL is presently overseen by the collective efforts of its promoters and directors. Promoters , Atul Ranchal and Rajesh Mahajan , each bring nearly two decades of industry experience, complemented by directors , Jitendra Pratap Singh, Dr. Durga Shankar Maity, and Bhushan Singh Rana, who also possess over 20 years of expertise. Directors are supported by a team of well-versed professionals having rich experience in their respective fields.